share_log

Evercore ISI Group Downgrades Bionomics to In-Line, Lowers Price Target to $6

Benzinga Real-time News ·  Dec 20, 2022 05:07

Evercore ISI Group analyst Joshua Schimmer downgrades Bionomics (NASDAQ:BNOX) from Outperform to In-Line and lowers the price target from $17 to $6.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment